Regional Analysis of the Tremfya Market

agregó una foto Health

2026-07-06 11:38:15 -

The rising burden of chronic inflammatory and autoimmune disorders has significantly increased demand for targeted biologic therapies. Among these, Tremfya (guselkumab) has emerged as a leading treatment option for moderate-to-severe plaque psoriasis and psoriatic arthritis. Strong Tremfya drug market growth, expanding guselkumab market applications, and increasing demand within...

0 Commentarios 0 Acciones 4 Views 0 Vista previa